Related references
Note: Only part of the references are listed.Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression
Yi-Ju Chen et al.
CELL (2020)
Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer
Qinchaung Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer
Daniel C. Liebler et al.
SCIENTIFIC REPORTS (2020)
Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis
Marwa O. El-Derany
BIOLOGY-BASEL (2020)
The Relationship Between Air Pollution and Lung Cancer in Nonsmokers in Taiwan
Chien-Hua Tseng et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity
Tokiyoshi Tanegashima et al.
CLINICAL CANCER RESEARCH (2019)
Accurate expression of PD-L1/L2 in lung adenocarcinoma cells: A retrospective study by double immunohistochemistry
Yusuke Shinchi et al.
CANCER SCIENCE (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition
Daniele Cretella et al.
CANCERS (2019)
Association of a PD-L2 Gene Polymorphism with Chronic Lymphatic Filariasis in a South Indian Cohort
Gopinath Venugopal et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naive advanced EGFR-mutant lung adenocarcinoma patients
Kuo-Hsuan Hsu et al.
LUNG CANCER (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Lung cancer in never smokers-the East Asian experience
Fei Zhou et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
In Brief: Myeloid-derived suppressor cells in cancer
S. Solito et al.
JOURNAL OF PATHOLOGY (2017)
Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer
Yohei Masugi et al.
CANCER IMMUNOLOGY RESEARCH (2017)
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer
Jennifer H. Yearley et al.
CLINICAL CANCER RESEARCH (2017)
Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors
I-Shou Chang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population
Yan-bin Chen et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2014)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes
Ching-Yao Yang et al.
EUROPEAN JOURNAL OF CANCER (2014)
Programmed death ligand-1 expression in non-small cell lung cancer
Vamsidhar Velcheti et al.
LABORATORY INVESTIGATION (2014)
Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
Yang Zhang et al.
ONCOTARGETS AND THERAPY (2014)
Risk factors for primary lung cancer among never smokers by gender in a matched case-control study
Yen-Li Lo et al.
CANCER CAUSES & CONTROL (2013)
Tumor B7-H1 and B7-H3 Expression in Squamous Cell Carcinoma of the Lung
Jennifer M. Boland et al.
CLINICAL LUNG CANCER (2013)
Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
Esdy N. Rozali et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Lung cancer in never smokers - A review
Sebastien Couraud et al.
EUROPEAN JOURNAL OF CANCER (2012)
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia
Qing Lan et al.
NATURE GENETICS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Pulmonary Tuberculosis Increases the Risk of Lung Cancer
Chen-Yi Wu et al.
CANCER (2011)
B7-H1 Overexpression Regulates Epithelial-Mesenchymal Transition and Accelerates Carcinogenesis in Skin
Yujia Cao et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Human gene expression profiles of susceptibility and resistance in tuberculosis
J. Maertzdorf et al.
GENES AND IMMUNITY (2011)
The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis Emphasis on Non-small Cell Lung Cancer
Roy M. Bremnes et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
Marguerite Ghiotto et al.
INTERNATIONAL IMMUNOLOGY (2010)
The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia
Chao Agnes Hsiung et al.
PLOS GENETICS (2010)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: A systematic review
Hui-Ying Liang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies
Bryan N. Howie et al.
PLOS GENETICS (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2
Eszter Lazar-Molnar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The multitude and diversity of environmental carcinogens
D. Belpomme et al.
ENVIRONMENTAL RESEARCH (2007)
A second generation human haplotype map of over 3.1 million SNPs
Kelly A. Frazer et al.
NATURE (2007)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
Classical and alternative activation of mononuclear phagocytes: Picking the best of both worlds for tumor promotion
Jo A. Van Ginderachter et al.
IMMUNOBIOLOGY (2006)
Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma
KY Chen et al.
CANCER (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
Hormonal factors and risk of lung cancer among women?
M Kreuzer et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
PD-L2 is a second ligand for PD-I and inhibits T cell activation
Y Latchman et al.
NATURE IMMUNOLOGY (2001)
Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis
SA Khuder
LUNG CANCER (2001)
Share Paper
